| ORIGINAL ARTICLE |
|
| Year : 2020 | Volume
: 152
| Issue : 3 | Page : 244-253 |
|
|
Study of long non-coding RNA highly upregulated in liver cancer (HULC) in breast cancer: A clinical & in vitro investigation
Reyhaneh Ravanbakhsh Gavgani1, Esmaeil Babaei1, Mohammad Ali Hosseinpourfeizi1, Ashraf Fakhrjou2, Vahid Montazeri3
1 Department of Animal Biology, School of Natural Sciences, University of Tabriz, Tabriz, Iran
2 Department of Pathology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Thoracic Surgery, Noor-Nejat Hospital, Tabriz, Iran
Correspondence Address:
Dr Esmaeil Babaei
Department of Animal Biology, School of Natural Sciences, University of Tabriz, Tabriz 51666
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijmr.IJMR_1823_18
|
|
|
Background & objectives: Breast cancer remains the most common malignancy among women worldwide. Long non-coding RNAs (lncRNAs) have been shown to play critical roles in tumour initiation and progression. This study was aimed to evaluate the potential role of lncRNA highly upregulated in liver cancer (HULC) in breast cancer.
Methods: The expression of HULC was evaluated in breast cancer patients and cell lines using real-time quantitative reverse transcription polymerase chain reaction. Small interfering RNA-based knockdown was also employed to study the potential role of HULC in breast cancer cell lines including ZR-75-1, MCF7 and MDA-MB-231.
Results: HULC was significantly upregulated in tumour tissues compared to non-tumoural margins (P <0.001). The receiver operating characteristic (ROC) curve analysis demonstrated the biomarker potential of HULC (ROCAUC=0.78, P <0.001). The HULC knockdown induced apoptosis and suppressed cellular migration in breast cancer cell lines.
Interpretation & conclusions: Our results indicated that HULC was upregulated in breast cancer and might play a role in tumourigenesis. The HULC may have a potential to be exploited as a new biomarker and therapeutic target in breast cancer.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Users Online: 2302
